Patents Examined by Leslie R. Deak
  • Patent number: 11173294
    Abstract: Apparatus and methods for controlled arterial/venous access are provided. The apparatus and methods may include a section of tubing anastomosed to a bodily lumen. A lumen clamping means may utilize a clamp manipulator to effectively seal the tubing, and the manipulator may be operated by two fingers. A needle receptor may be utilized, and the receptor may utilize a rotating member to guide a needle inserted from outside the body, in order ensure accurate placement into a channel. The channel may be in liquid communication with the tubing. The manipulator and the needle receptor may be palpable from outside the body.
    Type: Grant
    Filed: June 13, 2017
    Date of Patent: November 16, 2021
    Inventor: Tomislav Deur
  • Patent number: 11166849
    Abstract: Systems and devices for facilitating the flow of fluid between a first body region and a second body region are disclosed herein. The devices generally include a drainage and/or shunting element having a lumen extending therethrough for draining or otherwise shunting fluid between the first and second body regions. Further, devices configured in accordance with the present technology may be selectively adjustable to control the amount of fluid flowing between the first and second body regions. In some embodiments, for example, the devices comprise an actuation assembly that drives movement of a flow control element to modulate flow resistance through the lumen, thereby increasing or decreasing the relative drainage rate of fluid between the first body region and the second body region.
    Type: Grant
    Filed: April 3, 2020
    Date of Patent: November 9, 2021
    Assignee: Shifamed Holdings, LLC
    Inventors: Colin Mixter, Claudio Argento, Andrew Backus, Tom Saul
  • Patent number: 11166848
    Abstract: Adjustable flow glaucoma shunts are disclosed herein. In one embodiment, for example, an adjustable flow shunt can include an outflow drainage tube having a proximal inflow region and a distal outflow region. The proximal inflow region can include aperture(s) defining a fluid inlet area positioned to allow fluid to flow therethrough. The shunt further comprises an inflow control assembly at the proximal inflow region. The inflow control assembly can include a control element configured to slidably engage the proximal inflow region and a spring element. The spring element is configured to be activated by non-invasive energy and, upon activation, slidably move the control element along the proximal inflow region such that (a) the one or more apertures are accessible and have a first fluid flow cross-section or (b) the one or more apertures are at least partially covered by the control element and have a second, different fluid-flow cross-section.
    Type: Grant
    Filed: April 3, 2020
    Date of Patent: November 9, 2021
    Assignee: Shifamed Holdings, LLC
    Inventors: Colin Mixter, Claudio Argento, Andrew Backus, Tom Saul
  • Patent number: 11167071
    Abstract: A computer-implemented method and a computer system are disclosed. The computer system (200, 300) is suitable for detecting an operating state of a blood treatment machine (100, 201, 202, 20 . . . , 20n) or of a course of treatment in a blood treatment or a deviation from an ideal or uncomplicated operating state or a course of treatment.
    Type: Grant
    Filed: December 8, 2016
    Date of Patent: November 9, 2021
    Assignee: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
    Inventor: Pascal Kopperschmidt
  • Patent number: 11160961
    Abstract: The present technology is directed to adjustable interatrial shunting systems that selectively control blood flow between the left atrium and the right atrium of a patient. The adjustable interatrial devices include a shunting element having an outer surface configured to engage native tissue and an inner surface defining a lumen that enables blood to flow from the left atrium to the right atrium when the system is deployed across the septal wall. The systems can include an actuation assembly for selectively adjusting a geometry of the lumen and/or a geometry of a lumen orifice to control the flow of blood through the lumen.
    Type: Grant
    Filed: March 16, 2021
    Date of Patent: November 2, 2021
    Assignee: Shifamed Holdings, LLC
    Inventors: Brian Fahey, Scott Robertson, William L. Gould, William Jason Fox, Claudio Argento, Anthony Pantages, Miles Alexander, Peter Andriola
  • Patent number: 11141519
    Abstract: Disclosed is an artificial heart and lung apparatus (100) that can be connected to a patient (P), and transfers removed blood to a human body via a roller pump (120), the system including: the roller pump (120); a blood removal line (101) which transfers removed blood to the roller pump (120); a first blood transfer line (104) that transfers blood, which is transferred from the roller pump (120), to the human body; a blood removal rate sensor (111) that is provided in the blood removal line (101); and a control unit (140), in which the control unit (140) performs control such that a blood transfer rate of the roller pump (120) is in a specific range with respect to a blood removal rate measured by a blood removal rate sensor (111).
    Type: Grant
    Filed: June 12, 2018
    Date of Patent: October 12, 2021
    Assignee: SENKO MEDICAL INSTRUMENT MFG. CO., LTD.
    Inventors: Yoshinari Niimi, Masahiro Kamiya
  • Patent number: 11123518
    Abstract: A dual tip dialysis catheter has a proximal portion with connected lumens and a distal portion with diverging lumens. The lumens may separate at a split junction and diverge in a scissors like manner to reduce or eliminate a crack or gap adjacent to the split junction, thereby reducing clotting. A dual tip dialysis catheter may have forward openings configured to direct flow in opposite directions.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: September 21, 2021
    Assignee: Pristine Access Technologies, LTD.
    Inventor: Michael Gabriel Tal
  • Patent number: 11116625
    Abstract: Some embodiments disclosed herein relate to devices and methods for controlling placement of intraocular implants within a patient's eye including but not limited to placement within or near the collector ducts of Schlemm's canal located behind the trabecular meshwork. In some embodiments, a handheld peristaltic rotor device having a compression element can be positioned on a corneal surface of the eye and rotated to create a peristaltic movement of blood in one or more episcleral veins to generate blood reflux within Schlemm's canal such that one or more collector ducts, or channels, of Schlemm's canal can be located. In some embodiments, an implant can be implanted near the identified location of the one or more collector ducts, or channels.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: September 14, 2021
    Assignee: Glaukos Corporation
    Inventor: Charles Raymond Kalina, Jr.
  • Patent number: 11110216
    Abstract: A plasmapheresis system and a method for operating a plasmapheresis system are provided by which the volume/weight of anticoagulated plasma that is collected is optimized. In one example, a nomogram is provided that utilizes the donor's hematocrit to calculate the volume/weight of raw plasma within a plasma product having the maximum volume permitted by the FDA nomogram. In a plasmapheresis procedure having multiple collection phases followed by a reinfusion cycle in which concentrated red blood cells are returned to the donor, the volume of plasma product to be collected is calculated prior to the start of each collection cycle to account for the donor's increasing hematocrit, thus resulting in a greater total volume of plasma product to be collected during the plasmapheresis procedure.
    Type: Grant
    Filed: May 21, 2019
    Date of Patent: September 7, 2021
    Assignee: Fenwal, Inc.
    Inventors: Amit J. Patel, Samantha M. Planas, Walter T. Watts, Kyungyoon Min, Daniel R. Boggs
  • Patent number: 11090227
    Abstract: Methods and devices for transferring materials between containers are discussed. One such connector includes: a base; a first elongate structure having first and second ends, the first elongate structure extending from a first side of the base at the first end to the second end distal the base, the second end forming a first opening sized and configured to receive a first container; a duct extending through the base and having a first tip skirted on one or more sides by the first elongate structure; a first guard positioned within the first elongate structure, wherein the first guard comprises a first surface, and the first surface is located further away from the base than the first tip. When the first container is moved into the first opening, the first surface moves toward the base, and the first tip enters the first container, creating a fluid path for the first container.
    Type: Grant
    Filed: June 1, 2018
    Date of Patent: August 17, 2021
    Assignee: Bio-Rad Laboratories, Inc.
    Inventors: Alireza Ebrahim, Karl De Vore, John Sass
  • Patent number: 11077976
    Abstract: A device for transferring fluids includes a piercing member having a distal end and a proximal end and defines a longitudinal fluid channel. An opening is positioned at the distal end of the piercing member with the opening in fluid communication with the longitudinal fluid channel. Further, a sleeve having a proximal end and a distal end includes an extended position where the sleeve surrounds the piercing member and a retracted position where the sleeve is retracted from the distal end of the piercing member. The sleeve defines an opening at the distal end of the sleeve with a gap defined between the retractable sleeve and the piercing member.
    Type: Grant
    Filed: February 6, 2018
    Date of Patent: August 3, 2021
    Assignee: Becton Dickinson and Company Ltd.
    Inventors: Milan Ivosevic, Paul Paia Marici
  • Patent number: 11077241
    Abstract: The present invention is related to the field of tissue regeneration. It concerns more particularly new standardizations and medical devices for the preparation of A-PRP, PRP, BMC, fat tissue, alone or in combination with a biomaterial or cell extract.
    Type: Grant
    Filed: November 26, 2015
    Date of Patent: August 3, 2021
    Assignee: REGEN LAB USA LLC
    Inventor: Antoine Turzi
  • Patent number: 11064894
    Abstract: A system and method for determining the amount of fluid to be removed from a dialysis patient is disclosed. The system utilizes sensors and a computer. The computer obtains the input parameters from the sensors, along with information added directly by the user, and performs a forward algorithm to determine a recommended change in patient fluid level. As fluid is removed, the effect of the removal on the parameters is detected by the sensors and re-transmitted back to the computer. The computer then performs a backward algorithm to refine the variables used in the forward algorithm and obtain more accurate results. The system and method provide for changing the amount of fluid removed from the patient based on the results of the algorithm and the data received from the sensors.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: July 20, 2021
    Assignee: Medtronic, Inc.
    Inventors: Orhan Soykan, Christopher M. Hobot, Martin T. Gerber, VenKatesh R. Manda
  • Patent number: 11058581
    Abstract: Adjustable flow glaucoma shunts are disclosed herein. In one embodiment, for example, an adjustable flow shunt can include an outflow drainage tube having a proximal inflow region and a distal outflow region. The proximal inflow region can include aperture(s) defining a fluid inlet area positioned to allow fluid to flow therethrough. The shunt further comprises an inflow control assembly at the proximal inflow region. The inflow control assembly can include a control element configured to slidably engage the proximal inflow region and a spring element. The spring element is configured to be activated by non-invasive energy and, upon activation, slidably move the control element along the proximal inflow region such that (a) the one or more apertures are accessible and have a first fluid flow cross-section or (b) the one or more apertures are at least partially covered by the control element and have a second, different fluid-flow cross-section.
    Type: Grant
    Filed: July 20, 2018
    Date of Patent: July 13, 2021
    Assignee: Shifamed Holdings, LLC
    Inventors: Colin Mixter, Claudio Argento, Andrew Backus, Tom Saul
  • Patent number: 11045355
    Abstract: A system for preparation of an implant and ab interno insertion of the implant into an eye including a handle having one or more actuators and an elongated shaft having an outer sheath and an elongate member positioned within a lumen of the tubular outer sheath. The system includes a recess sized for holding a patch of material fixed relative to the handle and a cutting member movable relative to the handle and to the recess. The cutting member cuts the patch of material into an implant as the cutting member moves towards a cutting configuration. The implant, once cut, is axially aligned with the lumen of the tubular outer sheath. The inner elongate member is movable relative to the tubular outer sheath to advance the implant into a deployment position in the lumen of the tubular outer sheath for delivery into the eye. Related devices and methods are provided.
    Type: Grant
    Filed: April 29, 2020
    Date of Patent: June 29, 2021
    Assignee: Iantrek, Inc.
    Inventor: Tsontcho Ianchulev
  • Patent number: 11040132
    Abstract: Disclosed is an artificial heart and lung apparatus (100) that can be connected to a patient (P), and transfers removed blood to a human body via a roller pump (120), the system including: the roller pump (120); a blood removal line (101) which transfers removed blood to the roller pump (120); a first blood transfer line (104) that transfers blood, which is transferred from the roller pump (120), to the human body; a blood removal rate sensor (111) that is provided in the blood removal line (101); and a control unit (140), in which the control unit (140) performs control such that a blood transfer rate of the roller pump (120) is in a specific range with respect to a blood removal rate measured by a blood removal rate sensor (111).
    Type: Grant
    Filed: August 20, 2015
    Date of Patent: June 22, 2021
    Assignee: SENKO MEDICAL INSTRUMENT MFG. CO., LTD.
    Inventors: Yoshinari Niimi, Masahiro Kamiya
  • Patent number: 11026864
    Abstract: A locking element for a connector configured to connect two components of a fluid transfer system and a connector that comprises the locking element are described. The connector comprising the locking element is configured to provide continuous fluid channels between a first component and a second component of a fluid transfer system, the fluid is a hazardous drug and the connector is designated for safe and contamination-free transfer of said hazardous drug from first to second container while isolating the needle tips and causing no dangerous and harmful leaks.
    Type: Grant
    Filed: December 20, 2016
    Date of Patent: June 8, 2021
    Assignee: EQUASHIELD MEDICAL LTD.
    Inventors: Marino Kriheli, Eric Shem-Tov
  • Patent number: 11013664
    Abstract: In certain embodiments, a vial adaptor for removing liquid contents from a vial comprises a piercing member and a bag. The bag can be contained within the piercing member such that the bag is introduced to the vial when the vial adaptor is coupled with the vial. In some embodiments, the bag expands within the vial as liquid is removed from the vial via the adaptor, thereby regulating pressure within the vial. In other embodiments, a vial comprises a bag for regulating pressure within the vial as liquid is removed therefrom. In some embodiments, a vial adaptor is coupled with the vial in order to remove the liquid. In some embodiments, as the liquid is removed from the vial via the adaptor, the bag expands within the vial, and in other embodiments, the bag contracts within the vial.
    Type: Grant
    Filed: June 6, 2018
    Date of Patent: May 25, 2021
    Assignee: ICU Medical, Inc.
    Inventors: Thomas F. Fangrow, John M. Seifert
  • Patent number: 11013630
    Abstract: The present disclosure provides an inflatable weight control device that is implanted long-term with an endoscope in obese and bariatric human patients to promote early and prolonged satiety. The device includes a flexible, inflatable member coupled to a valve body assembly and an elongated durable module residing within the flexible member. The flexible member is selectively inflated to form two bulbs with a central passageway extending through the bulbs and the valve body assembly. Once the bulbs are inflated, the device is retained within the patient's pyloric valve to form a gastric outlet obstruction wherein chyme accumulates and then is directed through the central passageway to reach the patient's duodenum. Due to its unique configuration, the implanted device reduces gastric outflow which results in early and prolonged satiety when the patient consumes normal-sized meals or food portions, thereby reducing food consumption and increasing the patient's weight loss.
    Type: Grant
    Filed: April 23, 2018
    Date of Patent: May 25, 2021
    Assignee: AGT, Inc.
    Inventors: Gary Annunziata, Timothy Stippick
  • Patent number: 11007120
    Abstract: A cap assembly includes an access member configured for attachment to a reservoir. The access member includes a first port that enables needleless extraction of contents from the reservoir, and at least one second port that enables needled extraction of the contents from the reservoir. The cap assembly further includes a valve member positioned in or configured to be positioned in the access member to i) enable needleless extraction of the contents of the reservoir through the first port when the first port is attached to a needless extraction device, ii) enable needled extraction of the contents through the at least one second port, and iii) seal the contents of the reservoir at the first port and at the at least one second port prior to and subsequent to the needleless or needled extraction.
    Type: Grant
    Filed: December 4, 2020
    Date of Patent: May 18, 2021
    Assignee: KLIM-LOC, LLC
    Inventor: Robbie Klimek